1.09

1.57% 0.0169

After Hours: 1.04 -0.05 -4.59%

180 Life Sciences Corp (ATNF)

Overview News Price History Financials Discussions Forecast Stock Split

180 Life Sciences Corp stock is traded at $1.09, with a volume of 40,996. It is up +1.57% in the last 24 hours and up +45.06% over the past month. 180 Life Sciences Corp was formed as a clinical-stage biotechnology company, focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation, and fibrosis by employing research, and, where appropriate, combination therapy. In addition, it has acquired certain source code and intellectual property relating to the back-end technology platform to operate an online blockchain casino, and moving forward, it plans to focus the majority of its operations on the creation of the online blockchain casino, while looking to monetize certain prior development-stage therapeutic product candidates for unmet medical needs. It has one reportable operating segment, iGaming.

Previous Close:

$1.0731

Open:

$1.16

24h Volume:

40,996

Relative Volume:

0.31

Market Cap:

$6.83M

Revenue:

Net Income/Loss:

$-3.12M

P/E Ratio:

-0.2264

EPS:

-4.8149

Net Cash Flow:

$-2.69M

1W Performance:

-9.17%

1M Performance:

+45.06%

6M Performance:

-62.41%

1Y Performance:

-46.57%

1-Day Range:

$1.04

$1.2284

1-Week Range:

$1.02

$1.24

52-Week Range:

$0.6578

$17.75

180 Life Sciences Corp Stock (ATNF) Company Profile

Name

180 Life Sciences Corp

Sector

Healthcare (1153)

Industry

Biotechnology (676)

Phone

650-507-0669

Address

3000 EL CAMINO REAL, PALO ALTO

Employee

Twitter

Next Earnings Date

Latest SEC Filings

ATNF's Discussions on Twitter

Compare ATNF with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ATNF 180 Life Sciences Corp	1.09	6.83M	0	-3.12M	-2.69M	-4.8149
VRTX Vertex Pharmaceuticals Inc	424.99	128.84B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	527.78	65.38B	14.09B	4.50B	2.96B	39.28
ARGX Argen X Se Adr	549.65	39.67B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	251.15	33.82B	2.35B	-269.70M	-75.39M	-2.09
ONC Beigene Ltd Adr	231.99	27.60B	3.81B	-644.79M	-669.77M	-6.24

180 Life Sciences Corp Stock (ATNF) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-15-21	Initiated	Maxim Group	Buy

180 Life Sciences Corp Stock (ATNF) Latest News

May 02, 2025

180 Life Sciences Announces That the University of Oxford Has Been Awarded a Grant From the National Institute for Health and Care Research in the U.K. to Conduct a Clinical Trial in Post Operative Delirium/Cognitive Deficit in a Jointly Funded Program - Barchart.com

May 02, 2025

ATNF’s Stock Market Puzzle: Piecing Together 2023’s Performance - investchronicle.com

May 02, 2025

May 01, 2025

180 Life Sciences Gets Notice of Allowance for Method to Prevent POCD - marketscreener.com

May 01, 2025

MAGIC Nashville Showcases Premier Southeastern Women's Fashion Trends and Innovations - Digital Journal

May 01, 2025

180 Life Sciences (ATNF) Secures Patent Approval for POCD Treatm - GuruFocus

May 01, 2025

180 Life Sciences nears patent for post-surgery cognitive aid By Investing.com - Investing.com India

May 01, 2025

Patent Breakthrough: 180 Life Sciences Develops First Treatment to Prevent Post-Surgery Cognitive Decline in Elderly - Stock Titan

May 01, 2025

Apr 30, 2025

Budapest Draws in Summer Visitors for an Adventure Along the Danube - Digital Journal

Apr 30, 2025

180 Life Sciences (ATNF) Restructures Capital with Share Repurch - GuruFocus

Apr 30, 2025

180 Life Sciences to buy back shares, simplifies capital structure By Investing.com - Investing.com India

Apr 30, 2025

180 Life Sciences Settles Disputes with Elray Resources - TipRanks

Apr 30, 2025

180 Life Sciences Corp. Announces Share Repurchase | ATNF Stock News - GuruFocus

Apr 30, 2025

180 Life Sciences to buy back shares, simplifies capital structure - Investing.com Australia

Apr 30, 2025

180 Life Sciences Launches Massive 23% Share Reduction Plan: Key Details of $1M Strategic Buyback - Stock Titan

Apr 30, 2025

180 Life Sciences Corp. (NASDAQ:ATNF) Sees Large Increase in Short Interest - Defense World

Apr 30, 2025

Short Interest in Adlai Nortye Ltd. (NASDAQ:ANL) Decreases By 51.6% - Defense World

Apr 30, 2025

Apr 27, 2025

180 Life Sciences Corp. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Rule and Expands into the Global iGaming Sector - ACCESS Newswire

Apr 27, 2025

Apr 26, 2025

180 Life Sciences Corp. Announces Pricing of $2.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under NASDAQ Rules - ACCESS Newswire

Apr 26, 2025

Apr 25, 2025

180 Life Sciences’ (ATNF) “Sell (E+)” Rating Reiterated at Weiss Ratings - Defense World

Apr 25, 2025

Apr 22, 2025

Layoff Tracker: Tempest Axes 80% of Workforce - BioSpace

Apr 22, 2025

Apr 19, 2025

Alliancebernstein L.P. Has $1.12 Million Position in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World

Apr 19, 2025

Apr 17, 2025

Geode Capital Management LLC Sells 247,336 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World

Apr 17, 2025

Apr 14, 2025

Arrowstreet Capital Limited Partnership Has $312,000 Position in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World

Apr 14, 2025

Apr 11, 2025

12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga

Apr 11, 2025

Best Penny Stocks for Today (Charts Updated Daily) - Benzinga

Apr 11, 2025

Apr 09, 2025

Elray Resources Announces Strategic Sale of Crypto iGaming Technology - ADVFN

Apr 09, 2025

Pre-market Movers: VERO, WORX, QLGN, VINC... - RTTNews

Apr 09, 2025

Weiss Ratings Reiterates Sell (E+) Rating for 180 Life Sciences (NASDAQ:ATNF) - Defense World

Apr 09, 2025

180 Life Sciences’ (ATNF) “Sell (E+)” Rating Reaffirmed at Weiss Ratings - The AM Reporter

Apr 09, 2025

Apr 08, 2025

ATNF stock touches 52-week low at $0.74 amid market shifts - Investing.com India

Apr 08, 2025

12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga

Apr 08, 2025

Apr 05, 2025

180 Life Sciences Corp. Announces the Appointment of Stephen Shoemaker to Board of Directors - ACCESS Newswire

Apr 05, 2025

Mar 31, 2025

180 Life Sciences Corp. SEC 10-K Report - TradingView

Mar 31, 2025

ATNF stock touches 52-week low at $0.98 amid market shifts - Investing.com

Mar 31, 2025